NCT00085306View on ClinicalTrials.gov

Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Stage IV MelanomaRecurrent Melanoma
Interventions
BIOLOGICAL

recombinant interferon beta

recombinant interferon beta

Trial Locations (1)

44195

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Case Comprehensive Cancer Center

OTHER

NCT00085306 - Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma | Biotech Hunter | Biotech Hunter